Traynor Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $462K | Buy |
19,204
+1,443
| +8% | +$37.7K | 0.02% | 206 |
|
|
2026
Q1 | $493K | Sell |
17,761
-9,219
| -34% | -$245K | 0.03% | 175 |
|
|
2025
Q4 | $672K | Sell |
26,980
-2,797
| -9% | -$70.5K | 0.04% | 156 |
|
|
2025
Q3 | $759K | Sell |
29,777
-119
| -0.4% | -$2.94K | 0.04% | 147 |
|
|
2025
Q2 | $749K | Buy |
29,896
+3,157
| +12% | +$73.6K | 0.05% | 104 |
|
|
2025
Q1 | $678K | Sell |
26,739
-2,062
| -7% | -$54K | 0.06% | 110 |
|
|
2024
Q4 | $764K | Buy |
28,801
+1,473
| +5% | +$40K | 0.05% | 117 |
|
|
2024
Q3 | $791K | Buy |
27,328
+1,445
| +6% | +$42.2K | 0.05% | 114 |
|
|
2024
Q2 | $724K | Buy |
25,883
+4,104
| +19% | +$113K | 0.05% | 110 |
|
|
2024
Q1 | $604K | Buy |
21,779
+59
| +0.3% | +$1.64K | 0.05% | 131 |
|
|
2023
Q4 | $625K | Sell |
21,720
-11,893
| -35% | -$360K | 0.06% | 121 |
|
|
2023
Q3 | $1.11M | Buy |
33,613
+2,421
| +8% | +$85.6K | 0.14% | 77 |
|
|
2023
Q2 | $1.14M | Sell |
31,192
-2,313
| -7% | -$90K | 0.14% | 78 |
|
|
2023
Q1 | $1.37M | Buy |
33,505
+4,719
| +16% | +$204K | 0.2% | 66 |
|
|
2022
Q4 | $1.48M | Sell |
28,786
-952
| -3% | -$45.6K | 0.21% | 64 |
|
|
2022
Q3 | $1.3M | Buy |
29,738
+1,059
| +4% | +$51.5K | 0.23% | 57 |
|
|
2022
Q2 | $1.5M | Buy |
28,679
+104
| +0.4% | +$5.3K | 0.26% | 55 |
|
|
2022
Q1 | $1.48M | Sell |
28,575
-93,676
| -77% | -$4.86M | 0.19% | 61 |
|
|
2021
Q4 | $7.22M | Buy |
122,251
+5,818
| +5% | +$288K | 0.85% | 24 |
|
|
2021
Q3 | $5.01M | Sell |
116,433
-347
| -0.3% | -$15.4K | 0.69% | 36 |
|
|
2021
Q2 | $4.64M | Sell |
116,780
-2,581
| -2% | -$100K | 0.65% | 38 |
|
|
2021
Q1 | $4.32M | Sell |
119,361
-1,705
| -1% | -$60.5K | 0.71% | 37 |
|
|
2020
Q4 | $4.46M | Buy |
121,066
+27,809
| +30% | +$1.02M | 0.79% | 31 |
|
|
2020
Q3 | $3.38M | Buy |
93,257
+17,622
| +23% | +$618K | 0.77% | 29 |
|
|
2020
Q2 | $2.35M | Buy |
75,635
+22,760
| +43% | +$773K | 0.56% | 40 |
|
|
2020
Q1 | $1.64M | Buy |
52,875
+12,377
| +31% | +$422K | 0.58% | 35 |
|
|
2019
Q4 | $1.5M | Buy |
40,498
+4,082
| +11% | +$145K | 0.4% | 54 |
|
|
2019
Q3 | $1.24M | Buy |
36,416
+4,116
| +13% | +$150K | 0.39% | 57 |
|
|
2019
Q2 | $1.34M | Buy |
32,300
+504
| +2% | +$20K | 0.44% | 51 |
|
|
2019
Q1 | $1.28M | Buy |
31,796
+1,606
| +5% | +$64.3K | 0.43% | 47 |
|
|
2018
Q4 | $1.25M | Sell |
30,190
-1,338
| -4% | -$55.5K | 0.52% | 39 |
|
|
2018
Q3 | $1.32M | Sell |
31,528
-601
| -2% | -$23.1K | 0.43% | 44 |
|
|
2018
Q2 | $1.11M | Sell |
32,129
-2,080
| -6% | -$71.1K | 0.4% | 43 |
|
|
2018
Q1 | $1.15M | Buy |
34,209
+1,608
| +5% | +$55.3K | 0.47% | 41 |
|
|
2017
Q4 | $1.12M | Sell |
32,601
-185
| -0.6% | -$6.31K | 0.48% | 46 |
|
|
2017
Q3 | $1.11M | Sell |
32,786
-257
| -0.8% | -$8.26K | 0.53% | 42 |
|
|
2017
Q2 | $1.03M | Sell |
33,043
-682
| -2% | -$21.5K | 0.51% | 42 |
|
|
2017
Q1 | $1.08M | Buy |
33,725
+391
| +1% | +$12.3K | 0.6% | 34 |
|
|
2016
Q4 | $990K | Buy |
33,334
+2,774
| +9% | +$84.7K | 0.66% | 34 |
|
|
2016
Q3 | $945K | Buy |
30,560
+1,304
| +4% | +$43.6K | 0.67% | 36 |
|
|
2016
Q2 | $993K | Sell |
29,256
-35
| -0.1% | -$1.12K | 0.78% | 32 |
|
|
2016
Q1 | $823K | Buy |
29,291
+268
| +0.9% | +$7.66K | 0.66% | 34 |
|
|
2015
Q4 | $888K | Sell |
29,023
-942
| -3% | -$29.6K | 0.64% | 39 |
|
|
2015
Q3 | $893K | Sell |
29,965
-143
| -0.5% | -$4.58K | 0.77% | 28 |
|
|
2015
Q2 | $957K | Buy |
30,108
+20,430
| +211% | +$666K | 0.8% | 26 |
|
|
2015
Q1 | $319K | Sell |
9,678
-273
| -3% | -$8.68K | 0.31% | 72 |
|
|
2014
Q4 | $294K | Buy |
+9,951
| New | +$285K | 0.34% | 73 |
|
Other funds holding PFE
Traynor Capital Management's PFE Position: Q2 2026 in Review
Traynor Capital Management increased its Pfizer (PFE) stake by 8.1% in Q2 2026, buying an estimated $37.7K and bringing the position to 19,204 shares worth $462K. The position accounts for 0.02% of the portfolio, ranked #206.
Traynor Capital Management first reported a position in PFE in Q4 2014 and has held it in 47 quarters since. The position peaked at $7.22M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Traynor Capital Management held 19,204 shares of Pfizer worth $462K as of Q2 2026.
- Traynor Capital Management bought 1,443 Pfizer shares in Q2 2026, an estimated $37.7K.
- Pfizer made up 0.02% of Traynor Capital Management's portfolio in Q2 2026, its #206 holding.
- Traynor Capital Management first reported a position in Pfizer in Q4 2014 and has held it in 47 quarters since.
- Traynor Capital Management's Pfizer position peaked at $7.22M in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Traynor Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.